Close this search box.
Close this search box.

Epilepsy Research Institute welcomes new Chief Executive

The Epilepsy Research Institute is pleased to share the news that Rosemarie Pardington has now officially taken up post as our new Chief Executive.​ Rosemarie has previously held executive roles at Leonard Cheshire Disability and most recently at Young Epilepsy. As Director of Health & Research and Deputy CEO, Rosemarie was closely involved in the plans to establish the Institute with Young Epilepsy as a Founding Partner.

Rosemarie’s career in the Health and Research arena began in the NHS before moving onto the charity sector. During this time, she has continuously improved service delivery, transformed and grown operations to ensure success and sustainability. This has been achieved through solid leadership, developing positive team cultures and building strong internal and external networks.  
Outgoing Chief Executive Maxine Smeaton said, “Rosemarie and I have worked closely for five years, and I could not be more delighted that she is our next CEO. Rosemarie’s understanding of the needs of people affected by epilepsy, her experience, expertise and strategic leadership will guide the Institute towards realising a transformational future for epilepsy research.” 
Rosemarie thanked Maxine for a smooth transition and handover. She said, “Having worked at Young Epilepsy for the last seven years, I truly appreciate the positive impact epilepsy research makes to the lives of people with epilepsy. I feel extremely honoured to have been offered this position to enable me to continue to advance this important work”.   
The Epilepsy Research Institute’s Chair Professor Matthew Walker stated, “We are delighted and thrilled to welcome Rosemarie as our new Chief Executive. Rosemarie brings a wealth of experience, and we look forward to having her lead the team as we grow the epilepsy research ecosystem to achieve the Institute’s mission. 

The Board of Trustees, are also immensely grateful to our outgoing Chief Executive, Maxine, who led the transformation of Epilepsy Research UK to the Epilepsy Research Institute – the world’s first national research institute dedicated to epilepsy.” 
About the Epilepsy Research Institute 
The Epilepsy Research Institute was formed in October 2023 and serves as the central hub for the epilepsy research community. Our mission is to radically advance research into the causes, prevention and treatment of epilepsy and associated conditions. The Institute aims to strengthen the epilepsy research ecosystem by driving strategic investment and developing partnerships and collaborations between academia, the NHS, industry, funders, patient groups and people affected by epilepsy. Central to all we do is a culture of advocating and actioning the research priorities of people affected by epilepsy. 

Find out more about the Epilepsy Research Institute here. 

Share This Post